Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition)-Reference-Cited by-同舟云学术

Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition)

Published:2019-08 Issue:4 Volume:18 Page:307-312
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Xu Xiao,Chen Jun,Wei Qiang,Liu Zhi-Kun,Yang Zhe,Zhang Ming,Wang Guo-Ying,Gao Jie,Yang Zhao-Xu,Guo Wen-Yuan,Xing Tong-Hai,Shao Zhou,Xie Qin-Fen,Zheng Shu-Sen

Funder

National Science and Technology Major Project

The Changjiang Scholar Award

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference86 articles.

1. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies;Schünemann;BMJ,2008

2. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations;Guyatt;BMJ,2008

3. Oxford centre for evidence-based medicine-levels of evidence (March 2009). Oxford centre for evidence-based medicine, 2009 [cited 2018-11-01]. Available from:http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.

4. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

5. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience;Mazzaferro;Liver Transpl,2011

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends of liver transplantation in Asia;Updates in Surgery;2024-07-24

2. FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway;Aging;2024-07-09

3. Identification of hub genes and potential inhibitory compounds in the process of liver transplantation through transcriptome sequencing;Molecular and Cellular Probes;2023-12

4. Incorporation of protein induced by vitamin K absence or antagonist-II into transplant criteria expands beneficiaries of liver transplantation for hepatocellular carcinoma: a multicenter retrospective cohort study in China;International Journal of Surgery;2023-11-20

5. N⁶‐methyladenosine‐modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide;Clinical and Translational Medicine;2023-10